World's leading pharma services industry events to held at Frankfurt in 2011

Leading events organiser UBM International Media today announced that its flagship CPhI Worldwide tradeshow will return to Frankfurt, Germany for 2011.  Along with co-hosted events - P-MEC Europe for equipment, machinery and technology; ICSE for contract services and packaging; and BioPh Europe for the biopharma sector - the world's leading pharma services industry events will be held at Messe Frankfurt, from Tuesday 25 to Thursday 27 October.  

UBM anticipates that the 2011 events will build on the momentum that CPhI Worldwide has generated to date and continue to attract record levels of attendees, as it has done year on year since its 1990 inception.  With over 25,000 attendees, exhibitors, and vendors expected at the upcoming CPhI Worldwide, ICSE, P-MEC and BioPh 2010 event in Paris (Villepinte, 5-7 October), UBM is confident that number will again be surpassed in 2011 in Frankfurt.

Full details of the 2011 events – the twenty-second CPhI Worldwide – will be announced later this year.  However, some highlights will include the popular Breakfast Briefing seminars, which return for the fourth consecutive year, in addition to the CPhI Innovation Awards and the Speakers' Corner which will provide an extra meeting place between exhibitors and visitors.

CPhI Worldwide in Frankfurt will again feature the new, zoned layout which is being introduced at this year's Paris events, designed to make it easier for visitors to find the exhibitors they are looking for, giving more logical on-site navigation and leaving visitors with 'more talking, less walking' time. Zoning is already proving to be a popular initiative with nearly 80 new exhibitors already signed up for Paris. The zones attracting the most new exhibitors are the API zone and the General zone, both with over 25 new exhibitors, while each of the other zones—Intermediates, Fine Chemicals, Excipients and Custom Manufacturing—will also feature first time exhibitors.

Zoning will continue to be employed for the 2011 ICSE event, following its successful introduction in 2010. The Contract Research Zone will feature clinical trials, preclinical, Phase I-IV clinical trials and contract research companies, while the Packaging zone, which has 36 dedicated exhibitors in Paris, will feature a wide range of companies that provide packaging solutions within various stages of pharmaceutical processing. In response to market demand, ICSE Europe 2011 will also see the introduction of a North American Pavilion.

P-MEC Europe already has 50 exhibitors signed up for 2010 and is expected be a similar size to the record breaking 2009 event in Madrid. For 2011 the event will continue to evolve, with its focus on instrumental analysis, measuring and testing technologies, materials testing, quality control and laboratory equipment.  

Regarding the decision to return CPhI Worldwide to Frankfurt, Eliane van Doorn, UBM International Media's Group Director for Pharma events  commented, "Frankfurt was the venue for the first ever CPhI Worldwide in 1990 and has consistently proved popular among our exhibitors and visitors, given the prominence of Germany in the global chemicals industry. With total sales of euro 145.2 billion in 2009, Germany is ranked number one in Europe and number four worldwide, with leading fine chemicals companies such as BASF, Bayer and Evonik Industries all ranking in the top twenty highest grossing suppliers in the world."

Ms. Van Doorn continued, "Companies like these are the reason why Germany has been considered a true powerhouse in the pharmaceutical and fine chemicals industries for the last decade and why Frankfurt is an ideal host city for the CPhI events cluster."

When the inaugural CPhI event was first hosted by Frankfurt in 1990, a total of 250 visitors attended to meet with just 16 exhibitors. The events were most recently held in Frankfurt in 2008 attracting a then record 25,000 attendees, with more than 1,700 exhibitors from over 60 countries. 

Source:

UBM International Media

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine